JP2006502159A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502159A5
JP2006502159A5 JP2004534012A JP2004534012A JP2006502159A5 JP 2006502159 A5 JP2006502159 A5 JP 2006502159A5 JP 2004534012 A JP2004534012 A JP 2004534012A JP 2004534012 A JP2004534012 A JP 2004534012A JP 2006502159 A5 JP2006502159 A5 JP 2006502159A5
Authority
JP
Japan
Prior art keywords
saturated
unsaturated
branched
cyclic
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004534012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502159A (ja
Filing date
Publication date
Priority claimed from PCT/IL2003/000604 external-priority patent/WO2004023340A2/en
Application filed filed Critical
Priority claimed from PCT/IL2003/000735 external-priority patent/WO2004021974A2/en
Publication of JP2006502159A publication Critical patent/JP2006502159A/ja
Publication of JP2006502159A5 publication Critical patent/JP2006502159A5/ja
Abandoned legal-status Critical Current

Links

JP2004534012A 2002-09-05 2003-09-04 認知障害を予防するための向精神性のないカンナビノイド Abandoned JP2006502159A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40895802P 2002-09-05 2002-09-05
PCT/IL2003/000604 WO2004023340A2 (en) 2002-09-05 2003-07-23 Non-psychotropic cannabinoids for prevention of cognitive impairment
PCT/IL2003/000735 WO2004021974A2 (en) 2002-09-05 2003-09-04 Non-psychotropic cannabinoids for prevention of cognitive impairment

Publications (2)

Publication Number Publication Date
JP2006502159A JP2006502159A (ja) 2006-01-19
JP2006502159A5 true JP2006502159A5 (https=) 2006-10-19

Family

ID=31980345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004534012A Abandoned JP2006502159A (ja) 2002-09-05 2003-09-04 認知障害を予防するための向精神性のないカンナビノイド

Country Status (3)

Country Link
JP (1) JP2006502159A (https=)
AU (1) AU2003256059A1 (https=)
WO (1) WO2004021974A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025448A1 (en) 2004-07-22 2006-02-02 Cadila Healthcare Limited Hair growth stimulators
CA3204546A1 (en) * 2021-01-15 2022-07-21 Cambridge Cognition Limited Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US5284867A (en) * 1989-11-07 1994-02-08 Yissum Research Development Company Of The Hebrew University In Jerusalem NMDA-blocking pharmaceutical compositions
US6096740A (en) * 1990-11-06 2000-08-01 Ramot University Authority For Applied Research And Industrial Development Ltd. Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
US6211230B1 (en) * 1999-09-27 2001-04-03 The United States Of America As Represented By The Secretary Of The Army Method of reducing brain damage resulting from seizures

Similar Documents

Publication Publication Date Title
JP6931019B2 (ja) 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター
TWI376363B (en) Pharmaceutical combination for treating demyelinating disease
JP2009526831A5 (https=)
JP2015061883A (ja) Ｓ１ｐ受容体アゴニストの投与レジメン
JP2017105823A (ja) Ｓ１ｐ受容体調節因子の使用
RU2010116708A (ru) Бициклическое производное гамма-аминокислоты
MX2010005342A (es) Compuestos indola y metodos para tratar el dolor visceral.
RU2013109137A (ru) ЛЕКАРСТВЕННАЯ ДОЗИРОВАННАЯ ФОРМА, КОТОРАЯ СОДЕРЖИТ 6'-ФТОР-(N-МЕТИЛ-ИЛИ N,N-ДИМЕТИЛ)-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН ДЛЯ ЛЕЧЕНИЯ НОЦИЦЕПТИВНОЙ БОЛИ
AU9219298A (en) Method of increasing bone volume using non-naturally-occurring fp selective agonists
RU2010123028A (ru) Кортикостероиды для лечения диареи, индуцированной эпотилоном или производным эпотилона
JP6052175B2 (ja) 左室拡張機能改善剤
JP2023022243A (ja) 精神障害の治療における使用のためのイロペリドン代謝物
JP2006502159A5 (https=)
RU2017137008A (ru) Антагонисты толл-подобного рецептора 4 и применение при аутоиммунных заболеваниях печени
RU2008112181A (ru) Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3
CN101636391B (zh) 神经病理性疼痛的预防剂和/或治疗剂
US20220218677A1 (en) Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea
RU2006126828A (ru) Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза
RU2007111704A (ru) 4[(2,4-дихлоро-5-метоксифенил)амино]-6-алкокси-7-этинил-3-хинолинкарбонитрилы для лечения ишемического поражения
JP2009235069A (ja) ３’，５−ジ−２−プロペニル−（１，１’−ビフェニル）−２，４’−ジオールを有効成分として含有する視神経障害の予防又は治療剤
JP4362457B2 (ja) 神経因性疼痛治療剤
WO2000051585A2 (en) Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume
JPWO2006051797A1 (ja) 間質性膀胱炎の治療薬
JP4741131B2 (ja) 低血圧およびショックの治療または予防
JP2008535829A5 (https=)